Crossmark

<i>In situ</i> fabrication of MS@MnO<sub>2</sub> hybrid as nanozymes for enhancing ROS-mediated breast cancer therapy

Crossref DOI link: https://doi.org/10.1039/D0NR03931D

Published Online: 2020

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Zhu, Xufeng

Liu, Yanan

Yuan, Guanglong

Guo, Xian

Cen, Jieqiong

Gong, Youcong

Liu, Jie https://orcid.org/0000-0003-2237-9309
Gang, Ye
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81803027 & 21877051)

Science and Technology Department, Guangdong Province (2016A020217011)
License Information

Accepted Manuscript valid from 2021-10-16
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Jie Liu (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 22 May 2020; Accepted 25 September 2020; Accepted Manuscript published 16 October 2020; Advance Article published 4 November 2020; Version of Record published 12 November 2020